glp-1 and trump Dr Blitz: Medicare Deal for “Just What the Doctor Ordered” Pres. Donald Trump announced that

Blood glucose levels provide immediate feedback, and the risks of poor control are well understood

Aug 14: In what is expected to become a multibillion-dollar blockbuster, Pfizers BCMAxCD3 bispecific antibody Elrexfio (elranatamab-bcmm) has secured an FDA accelerated approval as another off-the-shelf treatment option for patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy

When hormone care eases hot flashes and improves sleep, many women find they have far more capacity for consistent nutrition and strength training, which makes a GLP-1 program easier to follow

Authorization was required for 5% or fewer of beneficiaries until 2024, then by 2025, it was required for nearly 100% (Figure 1)

Fortunately, this is manageable

Can switching to another GLP-1 medication prevent recurrence